» Articles » PMID: 12361605

Interaction of FGF, Ihh/Pthlh, and BMP Signaling Integrates Chondrocyte Proliferation and Hypertrophic Differentiation

Overview
Journal Dev Cell
Publisher Cell Press
Date 2002 Oct 4
PMID 12361605
Citations 167
Authors
Affiliations
Soon will be listed here.
Abstract

Mutations in fibroblast growth factor (FGF) receptor 3 lead to the human dwarfism syndrome achondroplasia. Using a limb culture system, we have analyzed the role of FGF signaling and its interaction with the Ihh/Pthlh and BMP pathways in regulating chondrocyte differentiation. In contrast to previous suggestions, we demonstrate that FGF signaling accelerates both the onset and the pace of hypertrophic differentiation. We furthermore found that FGF and BMP signaling act in an antagonistic relationship regulating chondrocyte proliferation, Ihh expression, and the process of hypertrophic differentiation. Importantly, BMP signaling rescues the reduced domains of proliferating and hypertrophic chondrocytes in a mouse model for achondroplasia. We propose a model in which the balance of BMP and FGF signaling adjusts the pace of the differentiation process to the proliferation rate.

Citing Articles

Fibroblast growth factor receptor 3 mutation promotes HSPB6-mediated cuproptosis in hypochondroplasia by impairing chondrocyte autophagy.

Chen J, He D, Yuan C, Li N, Shi B, Niu C J Orthop Translat. 2025; 51:68-81.

PMID: 39991457 PMC: 11847030. DOI: 10.1016/j.jot.2025.01.011.


Timing of resting zone parathyroid hormone-related protein expression affects maintenance of the growth plate during secondary ossification: a computational study.

Stoop J, Yokoyama Y, Adachi T Biomech Model Mechanobiol. 2024; 24(1):125-137.

PMID: 39549120 PMC: 11846766. DOI: 10.1007/s10237-024-01899-3.


Cellular and molecular mechanisms that shape the development and evolution of tail vertebral proportion in mice and jerboas.

Weber C, Weitzel A, Liu A, Gacasan E, Sah R, Cooper K bioRxiv. 2024; .

PMID: 39484405 PMC: 11527341. DOI: 10.1101/2024.10.25.620311.


Growth plate closure and therapeutic interventions.

Cho J, Jung H, Shim K Clin Exp Pediatr. 2024; 67(11):553-559.

PMID: 39463341 PMC: 11551597. DOI: 10.3345/cep.2023.00346.


Targeting FGFR for cancer therapy.

Zhang P, Yue L, Leng Q, Chang C, Gan C, Ye T J Hematol Oncol. 2024; 17(1):39.

PMID: 38831455 PMC: 11149307. DOI: 10.1186/s13045-024-01558-1.